Hanmi Pharmaceutical Co., Ltd. - Significant Ownership

Signature - Title
Hanmi Pharmaceutical Co., Ltd. - Haegon Shin, Managing Director, Global Business Division
Location
Seoul, Korea, Republic of
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Hanmi Pharmaceutical Co., Ltd..

Significant Ownership of Hanmi Pharmaceutical Co., Ltd.

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Aptose Biosciences Inc. Common Shares 19.9% $115K 509K Hanmi Pharmaceutical Co., Ltd. Mar 18, 2025

Schedules 13D/G Reported by Hanmi Pharmaceutical Co., Ltd.:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.